Back to Search
CARTER DIGGS, MD
MD
Public Health & General Preventive Medicine Physician
NPI: 1902069594Individual
Specialties, Licenses & Credentials
Public Health & General Preventive Medicine PhysicianPrimary
Preventive Medicine — Public Health & General Preventive Medicine
Code: 2083P0901X
0101014417(VA)
Research & Publications (20)
Report of a consultation on the optimization of clinical challenge trials for evaluation of candidate blood stage malaria vaccines, 18-19 March 2009, Bethesda, MD, USA.
PMID 19654061·Vaccine·2009
7-preclinical
Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya.
PMID 19262754·PLoS One·2009
3-trial
Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A.
PMID 19390585·PLoS One·2009
3-trial
Hepatic fat and adenosine triphosphate measurement in overweight and obese adults using 1H and 31P magnetic resonance spectroscopy.
PMID 18331237·Liver Int·2008
2-rct
Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trial.
PMID 18213374·PLoS One·2008
3-trial
Characteristics associated with unplanned extubations in a surgical intensive care unit.
PMID 18158389·Am J Crit Care·2008
8-other
Enzyme-linked immunosorbent assay for detection of Plasmodium falciparum histidine-rich protein 2 in blood, plasma, and serum.
PMID 18367583·Clin Vaccine Immunol·2008
7-preclinical
Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya.
PMID 16388879·Vaccine·2007
3-trial
Short interval between symptom onset and medical care as an indication of rapid onset of interstitial cystitis/painful bladder syndrome.
PMID 17542989·BJU Int·2007
8-other
Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research.
PMID 17442466·Vaccine·2007
3-trial
Assessing urgency in interstitial cystitis/painful bladder syndrome.
PMID 17275075·Urology·2007
8-other
Dysuria at onset of interstitial cystitis/painful bladder syndrome in women.
PMID 16979747·Urology·2006
8-other
Using the International Continence Society's definition of painful bladder syndrome.
PMID 16765165·Urology·2006
8-other
Safety and reactogenicity of an MSP-1 malaria vaccine candidate: a randomized phase Ib dose-escalation trial in Kenyan children.
PMID 17124529·PLoS Clin Trials·2006
8-other
Phase I safety and immunogenicity trial of FMP1/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine.
PMID 16356603·Vaccine·2006
3-trial
Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.
PMID 15755604·Vaccine·2005
6-review
The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites.
PMID 15618165·Infect Immun·2005
7-preclinical
Pre-clinical evaluation of the malaria vaccine candidate P. falciparum MSP1(42) formulated with novel adjuvants or with alum.
PMID 15364429·Vaccine·2004
4-observational
Update on the clinical development of candidate malaria vaccines.
PMID 15331843·Am J Trop Med Hyg·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1300 PENNSYLVANIA AVE, ROOM 3 07-013
WASHINGTON, DC 20523 - Phone
- (202) 715-5728
Quick Facts
- NPI
- 1902069594
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile